RETRACTED: The estrogen/ miR ‐338‐3p/ ADAM17 axis enhances the viability of breast cancer cells via suppressing NK cell's function
Environmental Toxicology · 2023
DOI: 10.1002/tox.23791 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Environmental Toxicology, 2023. Verfasst von Yijiu Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of general surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs, ADAM17 Protein. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: the Science and Technology Projects of Zhejiang Province.
Abstract (Originalsprache)
Natural killer (NK) cells are the critical elements of the innate immune response and implicated in rapidly recognizing and eliminating cancer cells. However, the tumor‐suppressive ability of NK cells is often impaired in several cancer types. The critical roles of microRNAs have been elucidated by increasing evidences, while the regulation of miR‐338‐3p in anti‐tumor activation of NK cells and its relationship with estrogen in breast cancer (BC) are still confusing. Here, miR‐338‐3p level was found to be significantly downregulated in BC tissues and estrogen receptor positive (ER + ) cells, this difference was more obvious in ER + patients or BC patients at advanced stage (TNM III and IV). MiR‐338‐3p level was shown to be downregulated by 17β‐estradiol in BC cells (MDA‐MB‐231 cells and MCF‐7) in vitro. MiR‐338‐3p overexpression decreased disintegrin and metalloprotease‐17 (ADAM17) secretion in MDA‐MB‐231 (ER − ) and MCF‐7 (ER + ) cells. In addition, miR‐338‐3p overexpression or treatment with anti‐ADAM17 antibody could down‐regulate granzyme B, CD16, and NKG2D in NK cells, which was reversed by human recombinant ADAM17. Furthermore, these educated NK cells could promote the viability of MDA‐MB‐231 or MCF‐7 cells. Taken together, our results demonstrate that miR‐338‐3p was negatively regulated by estrogen in BC cells, impairing NK cell's activity by the up‐regulation of ADAM17, and conversely promoted the viability of BC cells. Therefore, the estrogen/miR‐338‐3p/ADAM17 axis is critically implicated in BC pathogenesis and may provide potential targets for BC diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of general surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
- Department of general surgery, The first affiliated hospital of Ningbo University (Yuehu Campus), Ningbo, Zhejiang province, China.
- Department of colorectal surgery, The first affiliated hospital of Ningbo University (Waitan Campus), Ningbo, Zhejiang province, China.
ORCID-Profile: Jiangfan Zhu
Förderung
- the Science and Technology Projects of Zhejiang Province
Zitieren
APA
Shi, Y., Pan, J., Hang, C., Tan, L., Hu, L., Yan, Z., & Zhu, J. (2023). RETRACTED: The estrogen/ miR ‐338‐3p/ ADAM17 axis enhances the viability of breast cancer cells via suppressing NK cell's function. Environmental Toxicology. https://doi.org/10.1002/tox.23791
Vancouver
Shi Y, Pan J, Hang C, Tan L, Hu L, Yan Z, et al. RETRACTED: The estrogen/ miR ‐338‐3p/ ADAM17 axis enhances the viability of breast cancer cells via suppressing NK cell's function. Environmental Toxicology. 2023. doi:10.1002/tox.23791
BibTeX
@article{Shi2023,
author = {Shi, Yijiu and Pan, Jianhui and Hang, Chen and Tan, Lin and Hu, Li and Yan, Zhilong and Zhu, Jiangfan},
title = {RETRACTED: The estrogen/ miR ‐338‐3p/ ADAM17 axis enhances the viability of breast cancer cells via suppressing NK cell's function},
journal = {Environmental Toxicology},
year = {2023},
doi = {10.1002/tox.23791}
}
EUVIMED